Traditional Chinese medicine induced liver injury

Journal of Clinical and Translational Hepatology

Volumn 2, Issue 2, 2014, Pages 80-94

  Teschke, Rolf ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Herb induced liver injury; Herbal hepatotoxicity; Herbs; Traditional Chinese herbal medicine; Traditional Chinese medicine

Indexed keywords

EID: 84902173161     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2014.00003     Document Type: Review

References (122)

1. http://nccam.nih.gov/health/whatiscam/chinesemed.htm, accessed 10 January 2014
2. Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet 2008;372: 1938–1940. doi: 10.1016/S0140-6736(08)61354-9.
3. Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002;252:107–113. doi: 10.1046/j.13652796.2002.00999.x.
4. Ernst E. Methodological aspects of Traditional Chinese Medicine (TCM). Ann Acad Med Singapore 2006;35:773–774.
5. Tang JL, Zhan SY, Ernst E. Review of randomised controlled clinical trials of traditional Chinese medicine. BMJ 1999;319:160–161. doi: 10.1136/bmj.319.7203.160.
6. Posadzki P, Watson L, Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol 2013;69:295–307.
7. Teschke R, Schwarzenboeck A, Eickhoff A, Frenzel C, Wolff A, Schulze J. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin Drug Saf 2013;12:339–366. doi: 10.1517/14740338.2013.774371.
8. http://livertox.nih.gov/ChineseAndOtherAsianHerbalMedicines.htm, accessed 10 January 2014
9. Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: A tabular compilation of reported cases. Liver Int 2012;32:1543–1556. doi: 10.1111/j.1478-3231.2012.02864.x.
10. Shaw D. Toxicological risks of Chinese herbs. Planta Med 2010;76:2012– 2018. doi: 10.1055/s-0030-1250533.
11. Teschke R, Lebot V. Proposal for a Kava Quality Standardization Code. Food Chem Toxicol 2011;49:2503–2516. doi: 10.1016/j.fct.2011.06.075.
12. Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Herbal hepatotoxicity: A critical review. Br J Clin Pharmacol 2013;75:630–636.
13. Danan G, Bénichou C. Causality assessment of adverse reactions to drugs – I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46:1323–1330. doi: 10.1016/0895-4356(93)90101-6.
14. Teschke R, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol 2013; 19:2864–2882.
15. Teschke R, Eickhoff A, Schulze J. Drug and herb induced liver injury in clinical and translational hepatology: Causality assessment methods, quo vadis? J Clin Translat Hepatol2013;1:59–74. doi: 10.14218/JCTH.2013. D002X
16. Teschke R, Frenzel C, Schulze J, Schwarzenboeck A, Eickhoff A. Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests. World J Hepatol 2013;5:353–363.
17. Teschke R, Genthner A, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: Analysis of cases with initially reported positive reexposure tests. Dig Liver Dis 2014;46:264–269. doi: 10.1016/j.dld.2013.10.020.
18. Haller CA, Dyer JE, Ko R, Olson KR. Making a diagnosis of herbal-related toxic hepatitis. West J Med 2002:176:39–44.
19. Kao WF, Hung DZ, Tsai WJ, Lin KP, Deng JF. Podophyllotoxin intoxication: toxic effect of Bajiaolian in herbal therapeutics. Hum Exp Toxicol 1992;11: 480–487. doi: 10.1177/096032719201100607.
20. Chou SL, Chou MY, Kao WF, Yen DH, Yen LY, Huang CI, et al. Bajiaolian poisoning-a poisoning with high misdiagnostic rate. Am J Emerg Med 2010;28:85–89.
21. http://livertox.nih.gov/BaJiaoLian.htm, accessed 10 January 2014.
22. Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003;138:852–858. doi: 10.1001/archsurg.138.8.852.
23. Jang JS, Seo EG, Han C, Chae HB, Kim SJ, Lee JD, et al. Four cases of toxic liver injury associated with Dictamnus dasycarpus. Korean J Hepatol 2008; 14:206–212.
24. Perharic-Walton L, Murray V. Toxicity of traditional Chinese herbal remedies. Lancet 1992;340:674. doi: 10.1016/0140-6736(92)92209-X
25. Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs: possible toxic components. Gut 1995;36:146–147. doi: 10.1136/gut.36.1.146.
26. Vautier G, Spiller RC. Safety of complementary medicines should be monitored. BMJ 1995;311:633. doi: 10.1136/bmj.311.7005.633b.
27. Kang SH, Kim JI, Jeong KH, Ko KH, Ko PG, Hwang SW, et al. Clinical characteristics of 159 cases of acute toxic hepatitis. Korean J Hepatol 2008; 14:483–492.
28. Sohn CH, Cha MI, Oh BJ, Yeo WH, Lee JH, Kim W, et al. Liver transplantation for acute toxic hepatitis due to herbal medicines and preparations. J Korean Soc Clin Toxicol 2008;6:110–116.
29. Cortez E, Boulger C, Bernard A. Ban Tu Wan hepatotoxicity. BMJ Case Rep 2012; 2012. doi: 10.1136/bcr-2012-006438.
30. Yuen MF, Tam S, Fung J, Wong DK, Wong BC, Lai CL. Traditional Chinese Medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther 2006;24: 1179–1186. doi: 10.1111/j.1365-2036.2006.03111.x.
31. Motoyama H, Enomoto M, Yasuda T, Fujii H, Kobayashi S, Iwai S, et al. Drug-induced liver injury caused by a herbal medicine, bofu-tsu-sho-san. Nihon Shokakibyo Gakkai Zasshi 2008;105:1234–1239.
32. Sakamoto S, Takeshita S, Sassa S, Suzuki S, Ishikawa Y, Kudo H. Effects of colestimide and/or Bofu-tsusho-san on plasma and liver lipids in mice fed a high-fat diet. In vivo 2005;19:1029–1034.
33. http://livertox.nih.gov/Ephedra.htm, accessed 10 January 2014
34. Hwang SH, Park JA, Jang YS, Lee KM, Lee DS, Ahn BM, et al. Case of acute cholestatic hepatitis caused by the seeds of Psoralea-corylifolia. Korean J Hepatol 2001;7:341–344.
35. Nam SW, Baek JT, Lee DS, Kang SB, Ahn BM, Chung KW. A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (BohGol-Zhee). Clin Toxicol (Phila) 2005;43:589–591. doi: 10.1081/CLT200068863.
36. Cheung WI, Tse ML, Ngan T, Lin J, Lee WK, Poon WT, et al. Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related propriety medicine. Clin Toxicol (Phila) 2009;47:683–685. doi: 10.1080/15563650903059136.
37. Teschke R, Bahre R. Severe hepatotoxicity by Indian Ayurvedic herbal products: A structured causality assessment. Ann Hepatol 2009;8:258– 266.
38. Lee CH, Wang JD, Chen PC. Risk of liver injury associated with Chinese herbal products containing Radix bupleuri in 639,779 patients with hepatitis B virus infection. PLoS One 2011;6:e16064. doi: 10.1371/journal.pone.0016064.
39. Kamiyama T, Nouchi T, Kojima S, Murata N, Ikeda T, Sato C. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997;92:703–704.
40. Inoue H, Yamazaki S, Shimizu M, Uozki H, Goto T, Ohnishi S, et al. Liver injury induced by the Japanese herbal drug kamishoyosan. Gastroenterol Hepatol (N Y) 2011:7:692–695.
41. Adachi M, Saito H, Kobayashi H, Horie Y, Kato S, Yoshioka M, et al. Hepatic injury in 12 patients taking the herbal loss aids Chaso and Onshido. Ann Intern Med 2003;139:488–492. doi: 10.7326/0003-4819-139-6200309160-00012.
42. Lai V, Smith A, Thorburn D, Raman VS. Severe hepatic injury and adulterated Chinese medicines. BMJ 2006;332:304–305. doi: 10.1136/bmj.332.7536.304-b.
43. Yuen YP, Lai CK, Poon WT, Ng SW, Chan AY, Mak TW. Adulteration of overthe-counter slimming products with pharmaceutical analogues – an emerging threat. Hong Kong Med J 2007;13:216–220.
44. Kanda T, Yokosuka O, Tada M, Kurihara T, Yoshida S, Suzuki Y, et al. Nnitroso-fenfluramine hepatotoxicity resembling chronic hepatitis. J Gastroenterol Hepatol 2003;18:999–1000. doi: 10.1046/j.14401746.2003.03074.x.
45. Lin TJ, Tsai MS, Chiou NM, Deng JF, Chiu NY. Hepatotoxicity caused by Breynia officinalis. Vet Hum Toxicol 2002;44:87–88.
46. Lin TJ, Su CC, Lan CK, Jiang DD, Tsai JL, Tsai MS. Acute poisonings with Breynia officinalis-an outbreak of hepatotoxicity. J Toxicol Clin Toxicol 2003;41: 591–594. doi: 10.1081/CLT-120023760.
47. http://livertox.nih.gov/ChiRYun.htm, accessed 10 January 2014.
48. Allen BR, Parkinson R, Hollman A, Jones R, Harper JI, Davies EG,et al. Chinese herbs for eczema. Lancet 1990;336:177. doi: 10.1016/01406736(90)91696-8.
49. Graham-Brown R. Toxicity of Chinese herbal remedies. Lancet 1992;340:673. Reply: Rustin M, Atherton D. Lancet 1992;340:673–674. doi: 10.1016/0140-6736(92)92208-W.
50. Sanders D, Kennedy N, McKendrick MW. Monitoring the safety of herbal remedies: Herbal remedies have a heterogeneous nature. Br Med J 1995; 311:1569. doi: 10.1136/bmj.311.7019.1569a.
51. Yoshida EM, McLean CA, Cheng ES, Blanc PD, Somberg KA, Ferrell LD, et al. Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol 1996;91:2647–2648.
52. http://livertox.nih.gov/ShoSaikoTo_DaiSaikoTo.htm, accessed 10 January 2014.
53. Kim SY, Yim HJ, Ahn JH, Kim JH, Kim JN, Yoon I, et al. Two cases of toxic hepatitis caused by arrowroot juice. Korean J Hepatol 2009;15:504–509.
54. Bae SH, Kim DH, Bae YS, Lee KJ, Kim DW, Yoon JB, et al. Toxic hepatitis associated with Polygoni multiflori. Korean J Hepatol 2010;16:182–186.
55. Gono Y, Odaguchi H, Hayasaki T, Suzuki K, Oikawa T, Muranushi A, et al. Clinical analysis of cases with drug-induced liver injury for Kampo medicine. Kampo Med 2010;61:828–833. doi: 10.3937/kampomed.61.828.
56. Linnebur SA, Rapacchietta OC, Vejar M. Hepatotoxicity associated with chinese skullcap contained in Move Free Advanced dietary supplement: two case reports and review of the literature. Pharmacotherapy 2010;30:258– 262.
57. Yang L, Aronsohn A, Hart J, Jensen D. Herbal hepatotoxicity from Chinese skullcap: A case report. World J Hepatol 2012;4:231–233.
58. Dhanasekaran R, Owens V, Sanchez W. Chinese skullcap in Move Free arthritis supplement causes drug induced liver injury and pulmonary infiltrates. Case Reports Hepatol 2013; Article ID 965092. doi: org/10.1155/2013/965092
59. Kang HS, Choi HS, Yun TJ, Lee KG, Seo YS, Yeon JE, et al. A case of acute cholestatic hepatitis induced by Corydalis speciosa Max. Korean J Hepatol 2009;15:517–523.
60. Jorge OA, Jorge AD. Hepatotoxicity associated with the ingestion of Centella asiatica. Rev Esp Enferm Dig 2005;97:115–124. doi: 10.4321/S113001082005000200006.
61. Kim YJ, Ryu SL, Shim JW, Kim DS, Shim JY, Park MS, et al. A pediatric case of toxic hepatitis induced by Hovenia dulcis. Pediatr Gastroenterol Hepatol Nutr 2012;15:111–116. doi: 10.5223/pghn.2012.15.2.111.
62. Chau TN. Drug-induced liver injury: an update. Medical Bulletin 2008;13: 23–26.
63. Woolf GM, Petrovic LM, Rojter SE, Wainwright S, Villamil FG, Katkov WN, et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994;121:729–735. doi: 10.7326/0003-4819-12110-199411150-00001.
64. Horowitz RS, Feldhaus K, Dart RC, Stermitz FR, Beck JJ. The clinical spectrum of Jin Bu Huan toxicity. Arch Intern Med 1996;156:899–903. doi: 10.1001/archinte.1996.00440080101012.
65. Divinsky M. Case report: Jin Bu Huan – not so benign herbal medicine. Can Fam Physician 2002;48:1640–1642.
66. Picciotti A, Campo N, Brizzolara R, Giusto R, Guido G, Sinelli N, et al. Chronic hepatitis induced by Jin Bu Huan. J Hepatol 1998;28:165–167. doi: 10.1016/S0168-8278(98)80217-1.
67. http://livertox.nih.gov/JinBuHuan.htm, accessed 10 January 2014.
68. Wu GL, Yu GY, Chen J. Clinical analysis of hepatic veno-occlusive disease induced by Sedum aizoon. Zhongguo Zhong Yao Za Zhi 2008; 33: 2402– 2404.
69. Lin G, Wang JY, Li N, Li M, Gao H, Ji Y, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol 2011;54:666–673. doi: 10.1016/j.jhep.2010.07.031.
70. Gao XS, Xiao SS, He JF. Analysis of alkaloids in Sedum aizoon and establishment of hepatic veno-occlusive model in mice. Chin J Integr Trad West Med Dig 2006;14:311–313.
71. Gao H, Li N, Wang JY, Zhang SC, Lin G. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J Dig Dis 2012;13:33–39.
72. Wang JY, Gao H. Tusanqi and hepatic sinusoidal obstruction syndrome. J Dig Dis 2014;15:105–107.
73. Dai HF, Gao Y, Yang M, Yu CH, Gu ZY, Chen WX. Hepatic veno-occlusive disease induced by Gymura segetum: report of two cases. Hepatobiliary Pancreat Dis Int 2006;5:406–408.
74. Kumana CR, Ng M, Lin HJ, Ko W, Wu PC, Todd D. Herbal tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults. Gut 1985;26:101–104. doi: 10.1136/gut.26.1.101.
75. Kumana CR, Ng M, Lin HJ, Ko W, Wu PC, Todd D. Hepatic veno-occlusive disease due to toxic alkaloid in herbal tea. Lancet 1983;2:1360–1361. doi: 10.1016/S0140-6736(83)91112-1.
76. Culvenor CC, Edgar JA, Smith LW, Kumana CR, Lin HJ. Heliotropium lasiocarpum Fisch and Mey identified as cause of veno-occlusive disease due to herbal tea. Lancet 1986;1:978. doi: 10.1016/S01406736(86)91084-6.
77. Chen MY, Cai JT, Du Q. Hepatic veno-occlusive disease associated with the use of Gynura segetum. Eur J Intern Med 2007;18:609.
78. Li C, Liang XS, Li CZ. Sinusoidal obstruction syndrome associated with the ingestion of gynura root. Clin Toxicol (Phila) 2010;48:962–964. doi: 10.3109/15563650.2010.527851.
79. Fenkel JM, Navarro VJ. Herbal and dietary supplement-induced liver injury. Gastroenterol Hepatol 2011;7:695–696.
80. Duenas Sadornil C, Fabregas Piugtio S, Durandez R. Hepatotoxicity due to Camelia sinensis. Med Clin (Barc) 2004;122:677–678. doi: 10.1157/13061393.
81. Garcia-Moran S, Saez-Royuela F, Gento E, Lopez Morante A, Arias L. Acute hepatitis associated with Camellia tea and Orthosiphon stamineus ingestion. Gastroenterol Hepatol 2004;27:559–560. doi: 10.1016/S02105705(03)70527-5.
82. Peyrin-Biroulet L, Petitpain N, Kalt P, Ancel D, Petit-Laurent F, Trechot P, et al. Probable hepatotoxicity from epigallocatecol gallate used for phytotherapy. Gastroenterol Clin Biol 2004;28;404–406. doi: 10.1016/S0399-8320(04)94944-5.
83. Jimenez-Saenz M, Martinez-Sanchez Mdel C. Acute hepatitis associated with the use of green tea infusions. J Hepatol 2006;44:616–617. doi: 10.1016/j.jhep.2005.11.041.
84. Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med 2006:144:68–71. doi: 10.7326/0003-4819-144-1-200601030-00020.
85. García-Cortés M, Borraz Y, Lucena MI, Peláez G, Salmerón J, Diago M, et al. Liver injury induced by ‘‘natural remedies’’: an analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev Esp Enferm Dig 2008;100:688– 695.
86. Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, Mahady GB, et al. Safety of green tea extract: a systematic review by the US Pharmacopeia. Drug Saf 2008;31:469–484. doi: 10.2165/00002018-200831060-00003.
87. Navarro VJ, Bonkovsky HL, Hwang SI, Vega M, Barnhart H, Serrano J. Catechins in dietary supplements and hepatotoxicity. Dig Dis Sci 2013;58: 2682–2690. doi: 10.1007/s10620-013-2687-9.
88. Rossi S, Navarro VJ. Herbs and liver injury: a clinical perspective. Clin Gastroenterol Hepatol 2014; in press. DOI: 10.1016/j.cgh.2013.07.030.
89. Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol 1996; 91:1436–1438.
90. Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Druginduced acute liver failure: Results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065–2076. doi: 10.1002/hep.23937.
91. Borum ML. Fulminant exacerbation of autoimmune hepatitis after the use of Ma Huang. Am J Gastroenterol 2001;96:1654–1655.
92. Skoulidis F, Alexander GJ, Davies SE. Ma huang associated acute liver failure requiring liver transplantation. Eur J Gastroenterol Hepatol 2005;17: 581–584.
93. Joshi D, Cross TJ, Wong VS. Acute drug induced hepatitis secondary to a weight loss product purchased over the internet. Nutr J 2007;6:13.
94. http://livertox.nih.gov/ShouWuPian.htm, accessed 10 January 2014.
95. Cárdenas A, Restrepo JC, Sierra F, Correa G. Acute hepatitis due to shenmin: a herbal product derived from Polygonum multiflorum. J Clin Gastroenterol 2006;40:629–632. doi: 10.1097/00004836-20060800000014.
96. Panis B, Wong DR, Hooymans PM, De Smet PA, Rosias PP. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J Pediat Gastroenterol Nutr 2005;41:256–258. doi: 10.1097/01.MPG.0000164699.41282.67.
97. Jung KA, Min HJ, Yoo SS, Kim HJ, Choi SN, Ha CY, et al. Drug-induced liver injury: Twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum Thun. Gut Liver 2011;5:493–499. doi: 10.5009/gnl.2011.5.4.493.
98. Valente G, Sanges M, Campione S, Bellevicine C, De Franchis G, Sollazzo R, et al. Herbal hepatotoxicity: a case of difficult interpretation. Eur Rev Med Pharmacol Sci 2010;14:865–870.
99. But PP, Tomlinson B, Lee KL. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. Vet Hum Toxicol 1996;38:280–282.
100. Park GJ, Mann SP, Ngu MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol 2001;16:115–117. doi: 10.1046/j.1440-1746.2001.02309.x.
101. Battinelli L, Daniele C, Mazzanti G, Mastroianni CM, Lichtner M, Coletta S, Costantini S. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann Intern Med 2004;140:587–588.
102. Laird AR, Ramchandani N, deGoma EM, Avula B, Khan IA, Gesundheit N. Acute hepatitis associated with the use of an herbal supplement (Polygonum multiflorum) mimicking iron-overload syndrome. Clin Gastroenterol 2008;42:861–862. doi: 10.1097/MCG.0b013e3181492515
103. Furukawa M, Kasajima S, Nakamura Y, Shouzushima M, Nagatani N, Takinishi A, et al. Toxic hepatitis induced by Show-Wu-Pian, a Chinese herbal preparation. Inter Med 2010;49:1537–1540. doi: 10.2169/internalmedicine.49.3509.
104. Aiba T, Takahashi T, Suzuki K, Okoshi S, Nomoto M, Uno K, et al. Liver injury induced by a Japanese herbal medicine, sairei-to (TJ-114, Bupleurum and Hoelen combination, Chai-Ling-Tang). J Gastroenterol Hepatol 2007;22: 762–763. doi: 10.1111/j.1440-1746.2006.03373.x
105. Tsuda T, Yashiro S, Gamo Y, Watanabe K, Hoshino T, Oikawa T, et al. Discrepancy between clinical course and drug-induced lymphocyte stimulation tests in a case of saireito-induced liver injury accompanied by Sjögren syndrome. J Altern Complement Med 2010;16:501–505. doi: 10.1089/acm.2009.0183
106. Cohen SM, Heywood E, Pillai A, Ahn J. Hepatotoxicity associated with the use of White Flood, a nutritional supplement. Practical Gastroenterology 2012; October issue:45–48.
107. Itoh S, Marutani K, Nishijima T, Matsuo S, Itabashi M. Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995;40: 1845–1848. doi: 10.1007/BF02212712.
108. Hsu LM, Huang YS, Tsay SH, Chang FY, Lee SD. Acute hepatitis induced by Chinese hepatoprotective herb xiao-chai-hu-tang. J Chin Med Assoc 2006; 69:86–88. doi: 10.1016/S1726-4901(09)70119-4.
109. Teschke R, Wolff A, Frenzel C, Schwarzenboeck A, Schulze J, Eickhoff A. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment. World J Hepatol 2014; 6:17–32.
110. Chau TN, Cheung WI, Ngan T, Lin J, Lee KW, Poon WT, et al. Causality assessment of herb-induced liver injury using multidisciplinary approach and the Roussel Uclaf Causality Assessment Method (RUCAM). Clin Toxicol (Phila) 2011;49:34–39. doi: 10.3109/15563650.2010.537662.
111. Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol 2013;25:1093–1098.
112. Teschke R, Frenzel C, Wolff A, Eickhoff A, Schulze J. Drug induced liver injury: accuracy of diagnosis in published reports. Ann Hepatol 2014;13: 248–255.
113. Zhang L, Yang X, Sun Z, Qu Y. Retrospective study of adverse events of Polygonum multiflorum and risks control. Zhongguo Zhong Yao Za Zhi 2009;34:1724–1729.
114. Sangsuwan C, Udompanthurak S, Vannasaeng S, Thamlikitkul V. Randomized controlled trial of Tinospora crispa for additional therapy in patients with type 2 diabetes mellitus. J Med Assoc Thai 2004;87:543– 546.
115. Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013;144: 1419–1425. doi: 10.1053/j.gastro.2013.02.006.
116. Ko RJ. Adulterants in Asian patent medicines. N Engl J Med 1998;339:847.
117. Zhang L, Yan J, Liu X, Ye Z, Yang X, Meyboom R, et al. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: Current status and future perspective. J Ethnopharmacol 2012;140:519– 525. doi: 10.1016/j.jep.2012.01.058.
118. Son HS, Kim GS, Lee SW, Kang SB, Back JT, Nam SW, et al. Toxic hepatitis associated with carp juice ingestion. Korean J Hepatol 2006;12:103–106.
119. Mukai H, Watanabe T, Ando M, Katsumata N. An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients. Jpn J Clin Oncol 2006;36:808–810.
120. Chan DW, Yeung CK, Chan MK. Acute renal failure after eating raw fish gall bladder. BMJ 1985:290:897. doi: 10.1136/bmj.290.6472.897.
121. Xuan BH, Thi TX, Nguyen ST, Goldfarb DS, Stokes MB, Rabenou RA. Ichthyotoxic ARF after fish gallbladder ingestion: a large case series from Vietnam. Am J Kidney Dis 2003;41:220–224. doi: 10.1053/ajkd.2003.50008.
122. Kung SW, Chan YC, Tse ML, Lau FL, Chau TL, Tam MK. Acute renal failure and hepatitis following ingestion of carp gallbladder. Clin Toxicol (Phila) 2008;46:753–757. doi: 10.1080/15563650701687450.